Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 825 of 1475 entries
View as:

A Post-Marketing Surveillance Study to Assess the Safety of Fedratinib in Korean Patients With Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT06073847 Org: User:
Start: 06/13/23 End: 12/20/27 Due: 12/20/28

A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06846866 Org: User:
Start: 02/27/25 End: 06/19/25 Due: 06/19/26

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

Phase: N/A Priority: Normal
NCT ID: NCT05245500 Org: User:
Start: 06/09/22 End: 04/30/26 Due: 04/30/27

Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB)

Phase: N/A Priority: Normal
NCT ID: NCT01155427 Org: User:
Start: 05/31/09 End: 04/30/10 Due: 04/30/11

An Open Label Investigational Immuno-therapy Trial of Nivolumab in Cancers That Are Advanced or Have Spread

Phase: N/A Priority: Normal
NCT ID: NCT02832167 Org: User:
Start: 02/22/16 End: 06/24/21 Due: 06/24/22

A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327

Phase: N/A Priority: Normal
NCT ID: NCT04069143 Org: User:
Start: 10/01/19 End: 07/12/22 Due: 07/12/23

A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants

Phase: N/A Priority: Normal
NCT ID: NCT05985590 Org: User:
Start: 08/18/23 End: 12/11/23 Due: 12/11/24

Economic Burden in Adult Patients Diagnosed With Rheumatoid Arthritis (RA) Receiving Treatment With Biologic Disease-modifying Antirheumatic Drugs (bDMARDs)

Phase: N/A Priority: Normal
NCT ID: NCT01136694 Org: User:
Start: 05/31/09 End: 12/31/11 Due: 12/31/12

Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS

Phase: N/A Priority: Normal
NCT ID: NCT02546817 Org: User:
Start: 11/30/15 End: 09/29/17 Due: 09/29/18

Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01018745 Org: User:
Start: 01/31/10 End: 07/31/10 Due: 07/31/11

Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01666704 Org: User:
Start: 04/30/14 End: 05/31/16 Due: 05/31/17

A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their Infants

Phase: N/A Priority: Normal
NCT ID: NCT06133049 Org: User:
Start: 03/16/21 End: 08/31/31 Due: 08/31/32

An Investigational Immunotherapy Study of BMS-986299 Alone and in Combination With Nivolumab and Ipilimumab in Participants With Solid Cancers That Have Spread or Cannot be Removed

Phase: N/A Priority: Normal
NCT ID: NCT03444753 Org: User:
Start: 04/05/18 End: 02/14/22 Due: 02/14/23

A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)

Phase: N/A Priority: Normal
NCT ID: NCT05684289 Org: User:
Start: 01/03/23 End: 05/02/23 Due: 05/02/24

A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT03332186 Org: User:
Start: 03/15/18 End: 10/22/18 Due: 10/22/19

A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT03635983 Org: User:
Start: 09/21/18 End: 03/19/24 Due: 03/19/25

Real-world Patient Reported Outcomes Among Patients Treated With Camzyos

Phase: N/A Priority: Normal
NCT ID: NCT06551129 Org: User:
Start: 05/10/24 End: 06/30/27 Due: 06/30/28

A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT05556343 Org: User:
Start: 01/18/23 End: 02/27/25 Due: 02/27/26

Multiple Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01290575 Org: User:
Start: 02/28/11 End: 11/30/11 Due: 11/30/12

A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

Phase: N/A Priority: Normal
NCT ID: NCT00036608 Org: User:
Start: 01/31/02 End: 02/28/05 Due: 02/28/06

A Study of ddI in Children With AIDS Who Have Not Had Success With Zidovudine

Phase: N/A Priority: Normal
NCT ID: NCT00002280 Org: User:
Start: - End: 11/30/94 Due: 11/30/95

A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT06146660 Org: User:
Start: 07/24/24 End: 11/30/26 Due: 11/30/27

Study to Evaluate The Analgesic Efficacy and Safety of Intravenous Paracetamol in Subjects With Postoperative Pain After Total Hip Arthroplasty

Phase: N/A Priority: Normal
NCT ID: NCT00344045 Org: User:
Start: 04/30/06 End: 02/29/08 Due: 02/28/09

An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread

Phase: N/A Priority: Normal
NCT ID: NCT03446040 Org: User:
Start: 03/08/18 End: 08/29/24 Due: 08/29/25

A Phase 1, First-in-Human Study of BMS-986421 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05517837 Org: User:
Start: 09/13/22 End: 07/14/23 Due: 07/14/24